位置:首页 > 蛋白库 > HBS1L_MOUSE
HBS1L_MOUSE
ID   HBS1L_MOUSE             Reviewed;         682 AA.
AC   Q69ZS7; Q91Z32; Q9CVT2; Q9CZ95; Q9WTY5;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   03-AUG-2022, entry version 152.
DE   RecName: Full=HBS1-like protein;
GN   Name=Hbs1l; Synonyms=Hbs1, Kiaa1038;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   STRAIN=NIH Swiss; TISSUE=Embryo;
RX   PubMed=9872408; DOI=10.1016/s0014-5793(98)01492-6;
RA   Wallrapp C., Verrier S.-B., Zhouravleva G., Philippe H., Philippe M.,
RA   Gress T.M., Jean-Jean O.;
RT   "The product of the mammalian orthologue of the Saccharomyces cerevisiae
RT   HBS1 gene is phylogenetically related to eukaryotic release factor 3 (eRF3)
RT   but does not carry eRF3-like activity.";
RL   FEBS Lett. 440:387-392(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreatic islet;
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   STRAIN=C57BL/6J; TISSUE=Embryo, and Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=FVB/N; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-148 AND SER-150, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Liver, Lung, Pancreas, Spleen,
RC   and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-620, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [7]
RP   STRUCTURE BY NMR OF 51-120.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of HBS1-like domain in hypothetical protein BAB28515.";
RL   Submitted (AUG-2004) to the PDB data bank.
CC   -!- FUNCTION: Cotranslational quality control factor involved in the No-Go
CC       Decay (NGD) pathway. In the presence of ABCE1 and PELO, is required for
CC       48S complex formation from 80S ribosomes and dissociation of vacant 80S
CC       ribosomes. Together with PELO and in presence of ABCE1, recognizes
CC       stalled ribosomes and promotes dissociation of elongation complexes
CC       assembled on non-stop mRNAs; this triggers endonucleolytic cleavage of
CC       the mRNA, a mechanism to release non-functional ribosomes and to
CC       degrade damaged mRNAs as part of the No-Go Decay (NGD) pathway.
CC       {ECO:0000250|UniProtKB:Q9Y450}.
CC   -!- SUBUNIT: Interacts with the SKI complex.
CC       {ECO:0000250|UniProtKB:Q9Y450}.
CC   -!- INTERACTION:
CC       Q69ZS7; Q80X73: Pelo; NbExp=2; IntAct=EBI-16114976, EBI-16114899;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q69ZS7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q69ZS7-2; Sequence=VSP_013626;
CC       Name=3;
CC         IsoId=Q69ZS7-3; Sequence=VSP_013627, VSP_013628;
CC   -!- TISSUE SPECIFICITY: Detected in embryos. {ECO:0000269|PubMed:9872408}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class translation factor GTPase
CC       superfamily. Classic translation factor GTPase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01059}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD32369.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF087672; AAD23351.1; -; mRNA.
DR   EMBL; AK173091; BAD32369.1; ALT_INIT; mRNA.
DR   EMBL; AK006626; BAB24679.1; -; mRNA.
DR   EMBL; AK012856; BAB28515.1; -; mRNA.
DR   EMBL; BC010251; AAH10251.1; -; mRNA.
DR   CCDS; CCDS35862.1; -. [Q69ZS7-1]
DR   RefSeq; NP_062676.2; NM_019702.2. [Q69ZS7-1]
DR   PDB; 1UFZ; NMR; -; A=51-120.
DR   PDBsum; 1UFZ; -.
DR   AlphaFoldDB; Q69ZS7; -.
DR   SMR; Q69ZS7; -.
DR   BioGRID; 207968; 5.
DR   DIP; DIP-61684N; -.
DR   IntAct; Q69ZS7; 2.
DR   MINT; Q69ZS7; -.
DR   STRING; 10090.ENSMUSP00000020153; -.
DR   iPTMnet; Q69ZS7; -.
DR   PhosphoSitePlus; Q69ZS7; -.
DR   EPD; Q69ZS7; -.
DR   jPOST; Q69ZS7; -.
DR   MaxQB; Q69ZS7; -.
DR   PaxDb; Q69ZS7; -.
DR   PeptideAtlas; Q69ZS7; -.
DR   PRIDE; Q69ZS7; -.
DR   ProteomicsDB; 270946; -. [Q69ZS7-1]
DR   ProteomicsDB; 270947; -. [Q69ZS7-2]
DR   ProteomicsDB; 270948; -. [Q69ZS7-3]
DR   Antibodypedia; 32972; 383 antibodies from 27 providers.
DR   Ensembl; ENSMUST00000219915; ENSMUSP00000151689; ENSMUSG00000019977. [Q69ZS7-1]
DR   GeneID; 56422; -.
DR   KEGG; mmu:56422; -.
DR   UCSC; uc007eom.1; mouse. [Q69ZS7-3]
DR   UCSC; uc007eoo.1; mouse. [Q69ZS7-1]
DR   CTD; 10767; -.
DR   MGI; MGI:1891704; Hbs1l.
DR   VEuPathDB; HostDB:ENSMUSG00000019977; -.
DR   eggNOG; KOG0458; Eukaryota.
DR   GeneTree; ENSGT00940000156274; -.
DR   HOGENOM; CLU_007265_3_6_1; -.
DR   InParanoid; Q69ZS7; -.
DR   OMA; SVEDEHC; -.
DR   OrthoDB; 1150082at2759; -.
DR   PhylomeDB; Q69ZS7; -.
DR   TreeFam; TF105833; -.
DR   Reactome; R-MMU-429958; mRNA decay by 3' to 5' exoribonuclease.
DR   BioGRID-ORCS; 56422; 19 hits in 71 CRISPR screens.
DR   ChiTaRS; Hbs1l; mouse.
DR   EvolutionaryTrace; Q69ZS7; -.
DR   PRO; PR:Q69ZS7; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   RNAct; Q69ZS7; protein.
DR   Bgee; ENSMUSG00000019977; Expressed in spermatid and 262 other tissues.
DR   ExpressionAtlas; Q69ZS7; baseline and differential.
DR   Genevisible; Q69ZS7; MM.
DR   GO; GO:0005525; F:GTP binding; ISS:MGI.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0003746; F:translation elongation factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006412; P:translation; IBA:GO_Central.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR015033; HBS1-like_N.
DR   InterPro; IPR037189; HBS1-like_N_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000795; T_Tr_GTP-bd_dom.
DR   InterPro; IPR009000; Transl_B-barrel_sf.
DR   InterPro; IPR009001; Transl_elong_EF1A/Init_IF2_C.
DR   InterPro; IPR004160; Transl_elong_EFTu/EF1A_C.
DR   Pfam; PF00009; GTP_EFTU; 1.
DR   Pfam; PF03143; GTP_EFTU_D3; 1.
DR   Pfam; PF08938; HBS1_N; 1.
DR   PRINTS; PR00315; ELONGATNFCT.
DR   SUPFAM; SSF109732; SSF109732; 1.
DR   SUPFAM; SSF50447; SSF50447; 1.
DR   SUPFAM; SSF50465; SSF50465; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51722; G_TR_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Elongation factor;
KW   GTP-binding; Nucleotide-binding; Phosphoprotein; Protein biosynthesis;
KW   Reference proteome; Translation regulation.
FT   CHAIN           1..682
FT                   /note="HBS1-like protein"
FT                   /id="PRO_0000091492"
FT   DOMAIN          256..480
FT                   /note="tr-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01059"
FT   REGION          128..154
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          166..239
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          265..272
FT                   /note="G1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01059"
FT   REGION          321..325
FT                   /note="G2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01059"
FT   REGION          342..345
FT                   /note="G3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01059"
FT   REGION          404..407
FT                   /note="G4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01059"
FT   REGION          443..445
FT                   /note="G5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01059"
FT   COMPBIAS        140..154
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        203..236
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         265..272
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         342..346
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         404..407
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y450"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y450"
FT   MOD_RES         148
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         150
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         229
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y450"
FT   MOD_RES         620
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   VAR_SEQ         1..83
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9872408"
FT                   /id="VSP_013626"
FT   VAR_SEQ         141..167
FT                   /note="KSVISRSSQSESEIVPKVAKMTVSGKK -> VLFSSFGVSPQNVHHSYLQSE
FT                   NHLDSS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_013627"
FT   VAR_SEQ         168..682
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_013628"
FT   CONFLICT        201
FT                   /note="A -> R (in Ref. 1; AAD23351)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        251..252
FT                   /note="KR -> NAV (in Ref. 1; AAD23351)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        568
FT                   /note="G -> A (in Ref. 3; AAH10251)"
FT                   /evidence="ECO:0000305"
FT   HELIX           51..57
FT                   /evidence="ECO:0007829|PDB:1UFZ"
FT   HELIX           63..68
FT                   /evidence="ECO:0007829|PDB:1UFZ"
FT   HELIX           71..87
FT                   /evidence="ECO:0007829|PDB:1UFZ"
FT   TURN            88..91
FT                   /evidence="ECO:0007829|PDB:1UFZ"
FT   HELIX           94..103
FT                   /evidence="ECO:0007829|PDB:1UFZ"
FT   HELIX           108..120
FT                   /evidence="ECO:0007829|PDB:1UFZ"
FT   CONFLICT        Q69ZS7-3:146
FT                   /note="F -> L (in Ref. 3; BAB24679)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   682 AA;  75100 MW;  53ADD45EC0872968 CRC64;
     MARHRNVRGY NYDEDFEDDD LYGQSVEDDY CISPSTAAQF IYSRRDNPEE EYGYEDLRES
     SNSLLNHQLS EIDQARLYSC LDHMREVLGD AVPDDILTEA ILKHKFDVQK ALSVVLEQDG
     VQPWKEKSER AVCAGQPSKG KSVISRSSQS ESEIVPKVAK MTVSGKKQTM GFEVPGLTSE
     ENGLSVRAPH KGPPGDDVSV ASPNIPETGT PKSALPPPSL QTSEELGSTP TPVRKSGKLR
     QQIDVKAELE KRQGGKQLLN LVVIGHVDAG KSTLMGHMLY LLGNVNKRTM HKYEQESKKA
     GKASFAYAWV LDETGEERER GVTMDVGMTK FETTTKVITL MDAPGHKDFI PNMITGAAQA
     DVAVLVVDAS RGEFEAGFET GGQTREHGLL VRSLGVTQLA VAVNKMDQVN WQQERFQEIT
     GKLGHFLKQA GFKESDVAFI PTSGLSGENL TARSQSSDLT TWYKGMCLLE QIDSFKPPQR
     SIDKPFRLCV SDVFKDQGSG FCVTGKIEAG YIQTGDRLLA MPPNETCTAK GITLHDEPVD
     WAAAGDHVNL TLVGMDIIKI NVGCIFCGPK EPIKACTRFR ARILVFNIEV PITKGFPVLL
     HYQTVSEPAV IKRLISVLNK STGEVTKKKP KLLTKGQNAL VELQTQRPVA LELYKDFKEL
     GRFMLRYGGS TVAAGVVTEI KE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024